Clinical responses to ERK inhibitor (GDC-0994) treatment combinations predicted using a Quantitative Systems Pharmacology model of MAPK signaling in BRAF(V600E)-mutant colorectal cancer. (December 2016) - Kirouac, D.; Schaefer, G.; Chan, J.; Merchant, M.; Orr, C.; Liu, L.; Huang, A.; Moffat, J.; Gadkar, K.; Ramanujan, S.